Company Performance: Windlas Biotech's financial health, revenue growth, profitability, and debt levels directly influence its stock price.

Industry Trends: Overall growth and trends within the pharmaceutical and healthcare sectors, including generic drug pricing and regulatory changes, impact investor sentiment.

Market Sentiment: General market conditions, investor confidence, and macroeconomic factors like interest rates and inflation can affect stock valuations.

Regulatory Environment: Changes in pharmaceutical regulations, drug approvals, and patent laws can significantly affect Windlas Biotech's business prospects and stock price.

Competition: The competitive landscape within the pharmaceutical manufacturing and CDMO (Contract Development and Manufacturing Organization) space influences Windlas Biotech's market share and pricing power.

Raw Material Prices: Fluctuations in the cost of raw materials used in pharmaceutical manufacturing can affect Windlas Biotech's profit margins and, consequently, its stock price.

Global Economic Conditions: Economic slowdowns or recessions in key markets can reduce demand for pharmaceutical products and impact Windlas Biotech's revenue and stock price.

Investor Confidence: How confident investors are in the long-term prospects of Windlas Biotech and its management team plays a key role.

Specific News and Events: Company-specific announcements, such as earnings reports, new product launches, acquisitions, or partnerships, can cause immediate price fluctuations.

Valuation Metrics: How the stock is valued relative to its peers using metrics such as price-to-earnings ratio, price-to-sales ratio, and enterprise value-to-EBITDA ratio.

Supply Chain Disruptions: Disruptions to the global supply chain can impact Windlas Biotech's ability to source raw materials and manufacture products, affecting revenue and profitability.

Currency Fluctuations: Changes in exchange rates can impact Windlas Biotech's revenue and profitability, especially if it exports products or has significant foreign currency debt.

Technological Advancements: New technologies in pharmaceutical manufacturing can impact Windlas Biotech's competitive position and efficiency.